Evolution of anti-HIV drug candidates. Part 2: Diaryltriazine (DATA) analogues

Bioorg Med Chem Lett. 2001 Sep 3;11(17):2229-34. doi: 10.1016/s0960-894x(01)00411-5.

Abstract

A synthesis program directed toward improving the stability of imidoyl thiourea based non-nucleoside reverse transcriptase inhibitors (NNRTIs) led to the discovery of diaryltriazines (DATAs), a new class of potent NNRTIs. The synthesis and anti-HIV structure-activity relationship (SAR) studies of a series of DATA derivatives are described.

MeSH terms

  • Anti-HIV Agents / chemical synthesis
  • Anti-HIV Agents / chemistry*
  • Anti-HIV Agents / pharmacology*
  • Drug Design
  • HIV Reverse Transcriptase / antagonists & inhibitors*
  • HIV Reverse Transcriptase / genetics
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • Inhibitory Concentration 50
  • Reverse Transcriptase Inhibitors / chemistry
  • Reverse Transcriptase Inhibitors / pharmacology
  • Structure-Activity Relationship
  • Triazines / chemistry

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Triazines
  • HIV Reverse Transcriptase